Abbott Laboratories (ABT)
112.64
+0.41
(+0.37%)
USD |
NYSE |
Oct 04, 16:00
112.50
-0.14
(-0.12%)
Pre-Market: 20:00
Abbott Laboratories Shareholders Equity (Annual): 38.60B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 38.60B |
December 31, 2022 | 36.69B |
December 31, 2021 | 35.80B |
December 31, 2020 | 32.78B |
December 31, 2019 | 31.09B |
December 31, 2018 | 30.52B |
December 31, 2017 | 30.90B |
December 31, 2016 | 20.54B |
December 31, 2015 | 21.21B |
December 31, 2014 | 21.53B |
December 31, 2013 | 25.17B |
December 31, 2012 | 26.72B |
December 31, 2011 | 24.44B |
December 31, 2010 | 22.68B |
December 31, 2009 | 22.86B |
December 31, 2008 | 17.48B |
December 31, 2007 | 17.78B |
December 31, 2006 | 14.05B |
December 31, 2005 | 14.42B |
December 31, 2004 | 14.33B |
Date | Value |
---|---|
December 31, 2003 | 13.07B |
December 31, 2002 | 10.66B |
December 31, 2001 | 9.059B |
December 31, 2000 | 8.571B |
December 31, 1999 | 7.428B |
December 31, 1998 | 5.754B |
December 31, 1997 | 4.999B |
December 31, 1996 | 4.820B |
December 31, 1995 | 4.397B |
December 31, 1994 | 4.049B |
December 31, 1993 | 3.675B |
December 31, 1992 | 3.348B |
December 31, 1991 | 3.203B |
December 31, 1990 | 2.834B |
December 31, 1989 | 2.726B |
December 31, 1988 | 2.465B |
December 31, 1987 | 2.094B |
December 31, 1986 | 1.779B |
December 31, 1985 | 1.871B |
December 31, 1984 | 1.603B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
31.09B
Minimum
2019
38.60B
Maximum
2023
34.99B
Average
35.80B
Median
2021
Shareholders Equity (Annual) Benchmarks
Boston Scientific Corp | 19.28B |
Becton Dickinson & Co | 25.80B |
Intuitive Surgical Inc | 13.31B |
Globus Medical Inc | 3.998B |
Integra Lifesciences Holdings Corp | 1.588B |